Search

everythinglearnresearchcommunity

for

Search:↓

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

A COVID-19 patient had unusual nail discoloration and nail separation possibly due to the virus's effects on small blood vessels.

A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

High incidence of hair loss found in COVID-19 patients, but no severity correlation established.

Recreational drug use can cause misdiagnosed conditions and drug interactions in HIV patients.

Adiantum capillus-veneris may help with respiratory issues, but more research is needed.

Experts agree on the need for standardized definitions and education for post-COVID-19 conditions.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

More research is needed to understand sex and racial differences in long COVID.

The skin is vital for protection, temperature control, fluid balance, immunity, and sensing, with damage affecting daily life and mental health.

Cosmeceuticals are important for managing skin issues during the COVID-19 pandemic.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Many healthcare workers who had Covid-19 suffer from long-term symptoms like hair loss and fatigue, especially women.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Convolvulus arvensis ethanolic extract can potentially promote hair growth and reduce hair loss.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Using fat stem cells and blood cell-rich plasma together improves healing in diabetic wounds by affecting cell signaling.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.